CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Hiring the Right CRO to Improve Clinical Trial Outcomes

Hiring the Right CRO to Improve...

 Altasciences Receives Accreditation From College Of American Pathologists

Altasciences Receives Accreditation...

Life Science Marketing: Content Distribution for Businesses

Life Science Marketing: Content...

Protypia, Inc.'S Acquisition By Inotiv, Inc. Broadens The Company's Protein/Peptide Bioanalytical Capabilities

Protypia, Inc.'S Acquisition By...

Making the Most of Contract Research Organization Relationships

Making the Most of Contract Research...

How Cloudbased Lims Helps Cros

How Cloudbased Lims Helps Cros

MMS Holdings Announces New Pro-Bono Support Program

MMS Holdings Announces New Pro-Bono...

Inotiv Secures MilliporeSigmas BioReliance Genetic Toxicology Assets

Inotiv Secures MilliporeSigmas...

Hiring the Right CRO to Improve Clinical Trial Outcomes

Hiring the Right CRO to Improve...

 Altasciences Receives Accreditation From College Of American Pathologists

Altasciences Receives Accreditation...

Life Science Marketing: Content Distribution for Businesses

Life Science Marketing: Content...

Protypia, Inc.'S Acquisition By Inotiv, Inc. Broadens The Company's Protein/Peptide Bioanalytical Capabilities

Protypia, Inc.'S Acquisition By...

Making the Most of Contract Research Organization Relationships

Making the Most of Contract Research...

How Cloudbased Lims Helps Cros

How Cloudbased Lims Helps Cros

MMS Holdings Announces New Pro-Bono Support Program

MMS Holdings Announces New Pro-Bono...

Inotiv Secures MilliporeSigmas BioReliance Genetic Toxicology Assets

Inotiv Secures MilliporeSigmas...

Craig Lipset Joins Member and Executive Advisor of MedVector

Scott Stout, Co-Founder and CEO, MedVector | Tuesday, June 29, 2021
Tweet

Craig Lipset, a pioneer in decentralized clinical trials and an industry innovator, joins the MedVector board of directors and executive advisory board.


FREMONT, CA: Craig Lipset, a pioneer, and leader in the clinical trials industry, joins the MedVector team as a board member and executive advisor.


MedVector's ground-breaking Prime-Control Technology platform enables access to millions of potential clinical trial participants seen daily by physicians who are not interested in becoming study investigators. As a result, the company allows sponsors, clinical research organizations (CROs), and study recruiters to complete studies more quickly and reach a broader patient population from the comfort of their trusted neighborhood doctor's office.


Lipset's strategic role as an executive advisor includes providing insights and strategy to help the MedVector platform realize its full potential by integrating and complementing existing clinical trial processes and market solutions. He will also serve on the board of directors of MedVector and facilitate strategic collaborations with CROs, pharmaceutical companies, clinical trial sites, and patient recruitment leaders.


“MedVector is the first platform that addresses the misaligned incentives that stand in the way of physicians talking to their patients about clinical trials,” says Lipset.  “Clinical trial candidates are not medical mysteries. These patients typically have an existing diagnosis, they are on an existing therapy, and they value their trusted relationship with an existing local doctor.  Enabling these non-investigator physicians to have access to clinical trials as a care option is the 'holy grail’ of participant enrollment, and MedVector is doing just that.”


Founder and CEO Scott Stout. “His reputation and track record in the pharma and clinical trials arena will help propel us forward as we partner with CROs to increase enrollment.”


Craig Lipset is the Decentralized Trials & Research Alliance (DTRA) co-chair, the world's largest not-for-profit organization dedicated to accelerating the global adoption of decentralized research. The FDA, leading pharmaceutical companies, technology, service providers, and other healthcare organizations are among the more than 100 members of this growing collaborative.


Lipset advises major pharmaceutical companies on clinical innovation and is an adjunct assistant professor of health informatics at Rutgers University.


Before co-founding DTRA, Craig served as head of clinical innovation and venture partner at Pfizer, as a member of theTransCelerate Biopharma founding operations committee, and as a member of the founding management teams of two successful startups ventures, Perceptive Informatics and Adnexus Therapeutics.


Weekly Brief

loading
Top 10 Preeminent Cros – 2022
> <
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Qualities to Consider when Choosing Life Sciences Business Consultants for Your Firm

How Biotech Startups can Mitigate Risks in Order to Grow Sustainably

Cellf BIO's BioShincter to Undergo Phase 1 Trail to Test Fecal Incontinence Treatment

Fulcrum Therapeutics Announces CEO Transition

An Overview of Wholesalers' Roles in Complex Supply Chains

Veeva Opening Up Integration Module for Future Opportunities and Applications

Veeva Systems To Accelerate the CRM of Life Science Businesses

The Role of Technology in Advancing Clinical Trials

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/craig-lipset-joins-member-and-executive-advisor-of-medvector-nwid-429.html